Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 9407955)

1.

Nuclear location and cell cycle regulation of the BRCA2 protein.

Bertwistle D, Swift S, Marston NJ, Jackson LE, Crossland S, Crompton MR, Marshall CJ, Ashworth A.

Cancer Res. 1997 Dec 15;57(24):5485-8.

2.

BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2.

Bernard-Gallon D, Peffault De Latour M, Rio P, Favy D, Hizel C, Vissac C, Bignon YJ.

Int J Cancer. 2000 May 15;86(4):453-6.

PMID:
10797254
3.

Lessons learned from BRCA1 and BRCA2.

Zheng L, Li S, Boyer TG, Lee WH.

Oncogene. 2000 Dec 11;19(53):6159-75. Review.

4.
5.

Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers.

Staff S, Nupponen NN, Borg A, Isola JJ, Tanner MM.

Genes Chromosomes Cancer. 2000 Aug;28(4):432-42.

PMID:
10862052
6.

PML protein expression in hereditary and sporadic breast cancer.

Plevová P, Bouchal J, Fiurásková M, Foretová L, Navrátilová M, Zapletalová J, Curík R, Kubala O, Prokop J, Kolár Z.

Neoplasma. 2007;54(4):263-8.

PMID:
17822314
7.

BRCA1 and prostate cancer.

Rosen EM, Fan S, Goldberg ID.

Cancer Invest. 2001;19(4):396-412. Review.

PMID:
11405179
8.

Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.

Mote PA, Leary JA, Avery KA, Sandelin K, Chenevix-Trench G, Kirk JA, Clarke CL; kConFab Investigators.

Genes Chromosomes Cancer. 2004 Mar;39(3):236-48.

PMID:
14732925
9.
10.

Cell cycle control of BRCA2.

Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR, Iglehart JD.

Cancer Res. 1996 Oct 15;56(20):4590-4.

11.

Inherited breast cancer: an emerging picture.

Welcsh PL, Schubert EL, King MC.

Clin Genet. 1998 Dec;54(6):447-58. Review.

PMID:
9894790
12.

Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression.

Su LK, Wang SC, Qi Y, Luo W, Hung MC, Lin SH.

Oncogene. 1998 Nov 5;17(18):2377-81.

13.

Developmental studies of Brca1 and Brca2 knock-out mice.

Hakem R, de la Pompa JL, Mak TW.

J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):431-45. Review.

PMID:
10819537
14.

Overexpression of BRCA2 gene in sporadic breast tumours.

Bièche I, Noguès C, Lidereau R.

Oncogene. 1999 Sep 16;18(37):5232-8.

15.

Role of BRCA gene dysfunction in breast and ovarian cancer predisposition.

Scully R.

Breast Cancer Res. 2000;2(5):324-30. Epub 2000 Jul 13. Review.

16.

The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.

Chen PL, Chen CF, Chen Y, Xiao J, Sharp ZD, Lee WH.

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5287-92.

17.

Nuclear localization signals of the BRCA2 protein.

Yano K, Morotomi K, Saito H, Kato M, Matsuo F, Miki Y.

Biochem Biophys Res Commun. 2000 Apr 2;270(1):171-5.

PMID:
10733923
18.

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R.

Mol Cell. 1998 Sep;2(3):317-28.

19.

The BRCA2 is a histone acetyltransferase.

Siddique H, Zou JP, Rao VN, Reddy ES.

Oncogene. 1998 Apr 30;16(17):2283-5.

20.

Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.

Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ.

Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):741-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk